Following a limited submission
AWMSG advice |
|||
| Status: Recommended with restrictions | |||
Ketotifen (Ketofall®) is recommended as an option for restricted use within NHS Wales. Ketotifen (Ketofall®) should be restricted within its licensed indication for the symptomatic treatment of seasonal allergic conjunctivitis, to the subpopulation of patients who require a preservative-free treatment. Ketotifen (Ketofall®) is not recommended for use within NHS Wales outside of this subpopulation. |
|||
|
|||
Medicine details |
|||
| Medicine name | ketotifen (Ketofall®) | ||
| Formulation | 0.1 mg in 0.4 ml solution eye drops | ||
| Reference number | 3930 | ||
| Indication | Symptomatic treatment of seasonal allergic conjunctivitis |
||
| Company | Scope Ophthalmics Ltd | ||
| BNF chapter | Eye | ||
| Submission type | Limited | ||
| Status | Recommended with restrictions | ||
| Advice number | 0320 | ||
| NMG meeting date | 05/02/2020 | ||
| AWMSG meeting date | 17/03/2020 | ||
| Date of issue | 15/06/2020 | ||